Ticker
LPCNCompany Name
LIPOCINE INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Shareholders Equity | Market Capitalization | Price to Book |
---|---|---|---|
6/30/2025 | $ 17.13M | $ 16.69M | 0.97 |
3/31/2025 | $ 19.2M | $ 17.3M | 0.9 |
12/31/2024 | $ 21M | $ 17.66M | 0.84 |
9/30/2024 | $ 19.12M | $ 29.89M | 1.56 |
6/30/2024 | $ 21.21M | $ 23.48M | 1.11 |
3/31/2024 | $ 23.96M | $ 28.02M | 1.17 |
12/31/2023 | $ 20.37M | $ 19.3M | 0.95 |
9/30/2023 | $ 22.48M | $ 13.24M | 0.59 |
6/30/2023 | $ 28.55M | $ 26.63M | 0.93 |
3/31/2023 | $ 31.96M | $ 25.23M | 0.79 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Market Cap / Equity
(=) P/B
P/B for LIPOCINE INC is calculated as follows: Market Cap [ $ 91.96M ] / Equity [ $ 14.51M ]
(=) P/B [ 6.34 ]
Minimum
Sep 30, 2023
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.36K |
---|---|
min | 0 |
max | 8.04 |
average | 2.3 |
median | 1.63 |
std | 1.81 |